advertisement
Mobbili G 18
Showing records 1 to 18 | Display all abstracts from Mobbili G108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Minnelli C
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Cantarini M
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Minnelli C; Piva F
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Rusciano D; Amato R
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Cecati M; Armeni T
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Canovai A; Cammalleri M
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Mobbili G; Mobbili G; Galeazzi R
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Monte MD
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Galeazzi R; Melecchi A
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Minnelli C
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Melecchi A
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Minnelli C
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Cristaldi M
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Laudadio E; Mobbili G
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Corsaro R
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Mobbili G; Giorgini G
International journal of molecular sciences 2023; 24:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Rusciano D
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107757 Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors MT1 and MT2
Galeazzi R; Galeazzi R
International journal of molecular sciences 2023; 24:
